Research & Development

私色房综合网影视亚洲天堂2017手机版青娱乐最新官网在线看环球时报社评:军事强大且低调谦逊 这就是中国


  這里庭院寬敞,往日來的人也少,江心遠自己悶頭走出去,絲毫沒有察覺到別院二樓陽台落地窗前的一道身影。   這里庭院寬敞,往日來的人也少,江心遠自己悶頭走出去,絲毫沒有察覺到別院二樓陽台落地窗前的一道身影。私色房综合网影视   黎舟淡聲道︰“我就不用了吧,我不喜歡騎馬。”亚洲天堂2017手机版   那人趕忙買了個上周的呼啦圈,付了錢走了。 青娱乐最新官网在线看   江心遠還要發火,但是後面又緊跟著坐上來兩個人高馬大的保鏢,沉著一張臉把他擠在中間,江心遠再大的火氣也不敢隨意發作,只是一雙眼楮瞪著前面咬牙道︰“到底要去哪里?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo